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Abstract. 
 
Apoptosis is generally accompanied by a late 
phase of ceramide (Cer) production, the signiﬁcance of 
which is unknown. This study describes a previously un-
recognized link between Cer accumulation and phos-
phatidylserine (PS) exposure at the cell surface, a char-
acteristic of the execution phase of apoptosis resulting 
from a loss of plasma membrane phospholipid asymme-
try. Using a ﬂuorescent sphingomyelin (SM) analogue, 
 
N-
 
(
 
N
 
-[6-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]ca-
proyl]–sphingosylphosphorylcholine (C
 
6
 
-NBD-SM), we 
show that Cer is derived from SM, initially located in 
the outer leaﬂet of the plasma membrane, which gains 
access to a cytosolic SMase by ﬂipping to the inner leaf-
let in a process of lipid scrambling paralleling PS exter-
nalization. Lipid scrambling is both necessary and sufﬁ-
 
cient for SM conversion: Ca
 
2
 
1
 
 ionophore induces both 
PS exposure and SM hydrolysis, whereas scrambling-
deﬁcient Raji cells do not show PS exposure or Cer for-
mation. Cer is not required for mitochondrial or nu-
clear apoptotic features since these are still observed in 
Raji cells. SM hydrolysis facilitates cholesterol efﬂux to 
methyl-
 
b
 
-cyclodextrin, which is indicative of a loss of 
tight SM–cholesterol interaction in the plasma mem-
brane. We provide evidence that these biophysical al-
terations in the lipid bilayer are essential for apoptotic 
membrane blebbing/vesiculation at the cell surface: 
Raji cells show aberrant apoptotic morphology, 
whereas replenishment of hydrolyzed SM by C
 
6
 
-
NBD-SM inhibits blebbing in Jurkat cells. Thus,
SM hydrolysis, during the execution phase of apoptosis, 
results from a loss of phospholipid asymmetry and con-
tributes to structural changes at the plasma membrane.
Key words: CD95 • cholesterol • PS exposure • DNA 
damage • blebbing
 
Introduction
 
Apoptosis can be induced by such diverse stimuli as trig-
gering of death receptors (e.g., CD95 and tumor necrosis
factor receptor 1), growth factor withdrawal, hypoxia, or
DNA damage (e.g., etoposide or 
 
g
 
-radiation). These apop-
totic stimuli initiate unique signal transduction events, but
ultimately converge at the execution machinery of apop-
tosis, the caspase family of proteases. In addition to
caspase activation, ceramide (Cer)
 
1
 
 formation is a univer-
sal phenomenon in cells undergoing apoptosis (Hannun,
1996), but there is extensive debate about the significance
and the possible role of Cer in apoptosis (Hofmann and
Dixit, 1998; Kolesnick and Hannun, 1999). A rapid Cer re-
sponse (in minutes), which is suggestive of a second mes-
senger function, is observed in some cell systems using cer-
tain stimuli, whereas Cer formation at later time points (in
hours) after apoptosis induction is more generally ob-
served. The function of this late Cer response remains un-
known. The mechanism of Cer generation in response to
apoptotic stimuli has been the subject of extensive investi-
gation. Sphingomyelin (SM) hydrolysis by either a neutral
or acid sphingomyelinase (SMase) has been recognized as
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Abbreviations used in this paper:
 
 Cer, ceramide; DEVD-CHO,
Ac-Asp-Glu-Val-Asp aldehyde; DiOC
 
6
 
(3), 3,3’-dihexyloxacarbocya-
 
nine iodide; FB1, Fumonisin B1; 
 
g
 
-IR, 
 
g
 
-radiation; M
 
b
 
CD, methyl-
 
b
 
-cyclodextrin; NBD, 
 
N
 
-[6-[(7-nitro-benz-2-oxa-1,3-diazo-4-yl)amino]
 
caproyl]; NBD-Cer, N-(C
 
6
 
-NBD)-sphingosine; NBD-SM, C
 
6
 
-NBD-sphin-
gosylphosphorylcholine; PC, phosphatidylcholine; PL, phospholipids;
PS, phosphatidylserine; SM, sphingomyelin; SMase, sphingomyelinase;
zVAD-fmk, 
 
N
 
-benzoyloxycarbonyl-Val-Ala-Asp-fluoromethylketone. 
The Journal of Cell Biology, Volume 150, 2000 156
 
a universal pathway for Cer production (for review see Le-
vade and Jaffrézou, 1999). On the other hand, de novo Cer
biosynthesis also has been implicated in apoptosis induc-
tion by anticancer drugs (Bose et al., 1995).
We have previously shown that CD95-, etoposide-, and
 
g
 
-radiation–induced Cer formation in Jurkat T cells is a
slow event, coinciding with nuclear fragmentation, and is
secondary to caspase activation and cytochrome 
 
c
 
 release
from the mitochondria (Tepper et al., 1997, 1999). These
findings argue against a triggering role for Cer in apopto-
sis, at least in this cell system, but leave open the possibil-
ity that Cer has some function in the apoptotic execution
phase. One hallmark of the execution phase is the expo-
sure of phosphatidylserine (PS) at the cell surface (Martin
et al., 1995), which serves for recognition and subsequent
phagocytosis by macrophages (Schroit et al., 1985; Fadok
et al., 1992). PS exposure is the direct consequence of a
loss of phospholipid (PL) asymmetry in the plasma mem-
brane. The asymmetric PL distribution (i.e., SM and phos-
phatidylcholine [PC] in the outer leaflet and the amino-
phospholipids in the inner leaflet of the lipid bilayer)
is maintained by an ATP-dependent aminophospholipid
translocase that continuously transports PS and phosphati-
dylethanolamine (PE) to the inner leaflet (for reviews see
Zachowski, 1993; Zwaal and Schroit, 1997). Cell-surface
exposure of PS is believed to result from the coordinated
inhibition of the aminophospholipid translocase and the
activation of a Ca
 
2
 
1
 
-induced, bidirectional PL scrambling
(flip-flop) activity, causing the loss of lipid bilayer asym-
metry (Verhoven et al., 1995; Bratton et al., 1997). Scram-
bling of PL is thought to be mediated by a distinct enzyme,
PL scramblase (Zhou et al., 1997).
We were intrigued by the possibility that Cer formation
and PL scrambling (PS exposure), two lipid events in the
apoptotic execution phase, might be functionally linked.
To address this possibility, we used scrambling-competent
Jurkat T and SKW6.4 B cells and scrambling-deficient Raji
B cells, as well as fluorescent 7-nitrobenz-2-oxa-1,3-diazol-
4-yl-(NBD-) analogues of SM and PC. We show that, as a
consequence of the loss of PL asymmetry, SM moves from
the outer to the inner leaflet of the plasma membrane,
where it serves as a substrate for an intracellular SMase.
Thus, transbilayer movement of SM during apoptosis de-
termines substrate availability and thereby controls Cer
formation. Furthermore, we show that the breakdown of
SM causes concomitant cholesterol efflux and, thus, signifi-
cant alterations in the biophysical properties of the plasma
membrane, which is a prerequisite for membrane blebbing
and vesiculation at the surface of the apoptotic cell.
 
Materials and Methods
 
Materials
 
L
 
-3-[
 
14
 
C]serine (54 mCi/mmol), methyl-[
 
14
 
C]-choline chloride (58 mCi/
mmol) and 1
 
a
 
,2
 
a
 
(n)-[
 
3
 
H] cholesterol (49 Ci/mmol) were purchased
from Amersham Pharmacia Biotech. Mouse anti-human CD95 mAb
7C11 was from Immunotech. Ionomycin, BSA (essentially fatty acid–
free), acetyl-DEVD-aldehyde (DEVD-CHO) and 
 
N
 
-benzoyloxycarbo-
nyl-VAD-fluoroethylketone (zVAD-fmk) were from Calbiochem.
 
 Bacil-
lus
 
 
 
cereus
 
 sphingomyelinase, etoposide, propidium iodide (PI), fumoni-
sin B1 (FB1), and methyl-
 
b
 
-cyclodextrin (M
 
b
 
CD) were obtained from
Sigma Chemical Co. 3,3
 
9
 
-dihexyloxacarbocyanine iodide (DiOC
 
6
 
(3)),
 
N
 
-(
 
N
 
-[6-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]caproyl]-sphingosine
(C
 
6
 
-NBD-Cer), and 
 
N
 
-(
 
N
 
-[6-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]ca-
proyl]sphingosylphosphorylcholine (C
 
6
 
-NBD-SM) were from Molecular
Probes, Inc. FITC-labeled annexin V (APOPTEST™-FITC) was from
Nexins Research BV.
 
Cells
 
The J16 clone was derived by limiting dilution from the human T-acute
lymphoblastic leukemia cell line Jurkat and selected for uniform T cell
antigen receptor expression and CD95 sensitivity. J16 and SKW6.4 (Ep-
stein-Barr virus-transformed) B cells and Raji Burkitt lymphoma B cells
were cultured as previously described (Tepper et al., 1997). Before stim-
ulation, cells were resuspended in serum-free Yssel’s medium (Yssel et
al., 1984).
 
Apoptosis Assays
 
To measure nuclear fragmentation (subdiploid DNA content), cells were
lysed in 0.1% sodium citrate, 0.1% Triton X-100, and 50 
 
m
 
g/ml propidium
iodide (PI; Nicoletti et al., 1991) as described earlier (Tepper et al., 1999).
The loss of mitochondrial transmembrane potential (
 
DC
 
m
 
) was deter-
mined using DiOC
 
6
 
(3) (Zamzami et al., 1996). PS exposure was measured
using FITC-labeled annexin V as previously described (Koopman et al.,
1994). PI was added (5 
 
m
 
g/ml) before analysis to gate-out the cells that
had lost membrane integrity.
 
Measurement of SM Hydrolysis and Cer Quantification
 
Cells were metabolically labeled with 0.2 
 
m
 
Ci/ml each of either
[
 
14
 
C]serine or [
 
14
 
C]choline chloride for 40–48 h in Yssel’s medium,
washed, and further incubated for 3 h in Yssel’s medium before stimula-
tion. Lipids were extracted and radioactivity in SM and PC was analyzed
after TLC (Silica G60 plates) using chloroform/methanol/acetic acid/
water (60:30:8:5, vol/vol) as developing solvent. The water-soluble
[
 
14
 
C]choline metabolites in cells were quantified after TLC separation
(van Blitterswijk et al., 1991). In this case, radiolabeling of cells was fol-
lowed by a 24-h chase period before stimulation. Cer levels were deter-
mined after [
 
14
 
C]serine labeling as described previously (Tepper et al.,
1997), and were expressed relative to PS plus PE, which remained unal-
tered upon stimulation.
 
Analysis of NBD–Phospholipid Metabolism
 
Cells were washed once in Hanks’ balanced salt solution with 10 mM
Hepes (H/H), pH 7.4, and resuspended in the same medium supple-
mented with 1 mM CaCl
 
2
 
. NBD-lipid was dissolved in a minimum volume
of ethanol. H/H was added to this solution under vigorous vortexing to
yield a four times concentrated lipid mixture. Cells were preincubated for
10 min at 37
 
8
 
C with the NBD-lipid and subsequently stimulated. Lipids
were extracted and separated by TLC in chloroform/methanol/NH
 
4
 
OH
25% (70:30:5 vol/vol). NBD-lipids were visualized by UV light (Eagle
EyeII™; Stratagene) and quantitated by fluorescence spectrophotometry.
In some experiments, cells were labeled with NBD-SM during 30 min at
37
 
8
 
C, followed by back extraction (i.e., two consecutive incubations with
5% BSA for 4
 
8
 
C at 5 min) to remove exoleaflet-associated NBD-SM.
SKW6.4 cells were suspended in Yssel’s medium, treated with etoposide
(5 
 
m
 
g/ml) or irradiation (20 Gy) for 14 h (yielding PS exposure after ap-
proximately 10–12 h), washed, and resuspended in H/H. NBD-SM was
added (4 
 
m
 
M final concentration) during the last 20 min of the incubation
period, followed by lipid extraction and TLC analysis.
 
Efflux of Labeled Cholesterol
 
Cells were labeled for 2 d in complete medium containing 0.5 
 
m
 
Ci/ml
[
 
3
 
H]cholesterol, followed by a 24-h equilibration in Yssel’s medium with-
out radioactivity. Efflux of cholesterol from cells was determined in
Hanks’/Hepes (H/H) containing 0.08% M
 
b
 
CD, added 3 min before addi-
tion of 
 
B. cereus
 
 SMase (150 mU/ml). Cholesterol efflux during apoptosis
induction by anti-CD95 mAb (200 ng/ml) was measured at the indicated
time points, after centrifugation (for 2 min at 14,000 
 
g
 
) and resuspension
of cells in 1.25 ml H/H containing 0.08% M
 
b
 
CD to initiate cholesterol ef-
flux at 37
 
8
 
C. Aliquots of the cell suspension were harvested at different
time points and radioactivity in the supernatant was determined by scintil-
lation counting. The extent of cholesterol efflux was calculated from the
radioactivity initially present in the cell suspension. 
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Results
 
Correlation between PS Exposure and Cer Formation
 
Earlier work indicated that Cer accumulates relatively late
after apoptosis induction of Jurkat T cells via CD95 stimu-
lation or DNA-damaging regimens (Tepper et al., 1997,
1999). A slow and sustained Cer response has been de-
scribed for many different cell types using various apop-
totic stimuli, suggesting that late Cer production is a gen-
eral characteristic of the apoptotic execution phase. To
elucidate the mechanism and relevance of this late phase
of Cer formation, we set out to investigate a possible rela-
tionship between Cer production and PS exposure, an-
other lipid event that is usually observed during the execu-
tion phase. Fig. 1 A shows a close temporal correlation
between Cer formation, PS exposure, and nuclear frag-
mentation during CD95 stimulation of Jurkat T cells. Cer
formation could be dissociated from nuclear fragmenta-
tion by inhibiting effector caspases using the tetrapeptide
DEVD-CHO (Thornberry et al., 1997; Fig. 1 B). DEVD-
CHO inhibited nuclear fragmentation, whereas it only
marginally affected Cer formation and PS exposure in re-
sponse to etoposide or CD95 stimulation. Abrogation of
inducer and effector caspase activity using zVAD-fmk
(Thornberry et al., 1997) abolished both PS exposure and
Cer formation. The low level of inhibition of PS exposure
and Cer formation by DEVD-CHO can be explained by
the weak inhibitory effect of this compound on inducer
caspases (Garcia-Calvo et al., 1998). The similar kinetics
and caspase dependency of Cer formation and PS expo-
sure suggest that there is a causal relationship between
these events.
 
Cer Is Derived from Outer-leaflet SM
 
To define the source of Cer generated in CD95-stimulated
cells, we first assessed whether it resulted from SM hydro-
lysis or de novo synthesis. Metabolic labeling of cells with
[
 
14
 
C]serine allowed the detection and quantitation of
sphingolipids by TLC. Fig. 2 A shows that CD95 stimula-
tion induced a significant reduction in SM levels (
 
z
 
20%)
concomitant with Cer formation, which is indicative of
SMase activity. Fig. 2 B shows that CD95-induced Cer for-
mation was not affected by FB1, an inhibitor of de novo
Cer biosynthesis (Schroeder et al., 1994). The same holds
for other apoptotic stimuli, etoposide and 
 
g
 
-radiation (data
not shown). We confirmed that FB1 efficiently blocked de
novo sphingolipid biosynthesis (by 
 
.
 
85%), as evidenced
by the loss of [
 
14
 
C]serine incorporation into SM (Fig. 2 B,
inset). Thus, CD95-induced Cer formation results from
the breakdown of SM, without a role for Cer synthase ac-
tivity.
Plasma membrane phospholipids are asymmetrically dis-
tributed and, depending on the cell type, up to 90% of the
total cellular SM is localized in the outer leaflet (Ko-
val and Pagano, 1991). We quantified this pool of SM us-
ing bacterial sphingomyelinase (bSMase). Approximately
70% of total cellular SM, radiolabeled either in the polar
headgroup or in the sphingoid backbone, was degraded by
bSMase. The remaining intracellular pool was resistant to
treatment, even upon prolonged incubation (Fig. 2 C). To
define the pool of SM that is hydrolyzed during apoptosis,
cells were treated simultaneously with bSMase and anti-
CD95 mAb. If distinct cellular pools were involved, CD95
ligation should induce an additional breakdown of SM.
However, the combined treatment of cells with bSMase
and anti-CD95 mAb did not result in a greater loss of
SM than that observed with bSMase alone (Fig. 2 C).
CD95 signaling was effective under these conditions, as
determined by nuclear fragmentation (results not shown).
These findings suggest that the CD95-induced SMase ac-
tivity and exogenous bSMase hydrolyze the same pool of
SM (i.e., the one residing in the outer leaflet of the plasma
membrane).
To further substantiate this notion, we monitored the fate
of the fluorescent SM analogue 
 
N-
 
(
 
N
 
-[6-[(7-nitrobenz-2-
oxa-1,3-diazol-4-yl)amino]caproyl]–sphingosylphosphoryl-
choline (NBD-SM), which inserts into the outer leaflet of
Figure 1. Cer formation is as-
sociated with PS exposure.
(A) Time course of CD95-
induced Cer formation, PS
exposure, and nuclear frag-
mentation in Jurkat cells.
Sphingolipids were labeled to
equilibrium with [14C]serine.
Cells were stimulated with
anti-CD95 mAb (200 ng/ml)
for the indicated periods of
time. Cer formation was as-
sessed by TLC. PS exposure
and nuclear fragmentation
were analyzed by annexinV-
FITC staining of intact cells or propidium iodide staining of nuclei, respectively. Data shown are of one experiment performed three
times with similar results. Cer data points represent the mean 6 SD of three individual measurements. The other data points represent
individual measurements. (B) CD95- and etoposide-induced Cer formation, PS exposure, and nuclear fragmentation were determined
in parallel in the presence and absence of caspase inhibitors. Jurkat cells were radiolabeled as described above, left untreated (black
bars) or preincubated for 2 h with zVAD-fmk (50 mM; gray bars) or DEVD-CHO (100 mM; white bars), and then exposed to anti-CD95
mAb (200 ng/ml) during 4 h or etoposide (10 mg/ml) during 16 h. Data are individual measurements within one experiment representa-
tive of at least four separate experiments. 
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the plasma membrane (Koval and Pagano, 1990). We in-
vestigated whether cells undergoing apoptosis can metab-
olize NBD-SM. Indeed, CD95 stimulation resulted in a
progressive hydrolysis of NBD-SM to NBD-Cer (Fig. 3, A
and B), with similar kinetics to those observed for endoge-
nous SM conversion (Fig. 2 A). NBD-phosphatidylcholine
(NBD-PC) was not susceptible to degradation to either
lysoPC, phosphatidic acid, or diacylglycerol (data not
shown), indicating that SM to Cer conversion is specific
and does not reflect general lipid breakdown. The appear-
ance of a small amount of NBD-Cer in untreated control
cells (Fig. 3 A) most likely reflects hydrolysis of NBD-SM
that has entered the cell via endocytosis (Koval and Pa-
gano, 1990, 1991). This pool of NBD-Cer was further
metabolized by glycosylation to NBD-glucosylceramide,
whereas the NBD-Cer formed during CD95 stimulation
was not (Fig. 3 A). Apparently, NBD-Cer derived from
endocytosed NBD-SM is further glycosylated in the Golgi
apparatus, whereas CD95-induced NBD-Cer does not
reach this site, but rather, Cer glycosylation seems to be in-
hibited in apoptotic cells (Fig. 3 C). To provide evidence
that CD95-mediated Cer formation is derived from an SM
pool in the outer leaflet of the plasma membrane and not
from endocytosed NBD-SM, we labeled cells with NBD-
SM for 30 min at 37
 
8
 
C to allow labeling of intracellular
membranes, and then depleted exoleaflet NBD-SM via
BSA back extraction (Van Meer et al., 1987; Koval and
Pagano, 1990) before CD95 stimulation. Fig. 3 C shows
that, after back extraction, CD95 is no longer capable of
inducing NBD-Cer formation, indicating that this SMase
activity utilizes NBD-SM from the exoleaflet and not the
pool of internalized NBD-SM. Of note, NBD-GlcCer was
much less susceptible to BSA back extraction (Fig. 3 C),
reflecting its predominant localization to intracellular
membranes. To ensure that the phenomenon of outer leaf-
let NBD-SM hydrolysis was not restricted to Jurkat T cells
and/or CD95-induced apoptosis, we also analyzed NBD-
Cer production in SKW6.4 cells (Epstein-Barr virus–trans-
formed B cells) during etoposide- or 
 
g
 
-radiation–induced
apoptosis. Because apoptosis induction by these stimuli is
much slower than via death receptor ligation, NBD-SM
was presented to the cells for only 20 min to avoid high
background levels of NBD-Cer. Similar to the Jurkat/
CD95 system, SKW6.4 cells showed increased NBD-Cer
production upon DNA damage–induced apoptosis (Fig. 3
D), which temporally associated with PS exposure (data
not shown). Taken together, these results indicate that dis-
tinct apoptotic stimuli induce late Cer formation through
hydrolysis of a SM pool that is derived from the outer leaf-
let of the plasma membrane.
 
SM Is Hydrolyzed Intracellularly after Lipid Scrambling
 
If outer leaflet SM is the source of Cer, it has to redistrib-
ute within the lipid bilayer to gain access to the hydrolyz-
ing enzyme, because SMases act intracellularly (Linardic
and Hannun, 1994; Andrieu et al., 1996; Liu et al., 1998).
To confirm that SM is hydrolyzed intracellularly, we ana-
lyzed the production of water-soluble choline metabolites
in the cytosol. Jurkat cells were labeled with [
 
14
 
C]choline,
which incorporates into the polar headgroup of SM and
PC, and then triggered to undergo apoptosis via the CD95
receptor. We detected no increase in the intracellular level
of [
 
14
 
C]phosphocholine, a direct product of SMase activity
(Table I). However, apoptotic cells showed increased lev-
els of CDP-choline (Table I), which is likely to be derived
Figure 2. CD95-induced Cer is derived from SM, not from de novo biosynthesis. (A) Jurkat cells labeled with [14C]serine were stimu-
lated with anti-CD95 mAb (200 ng/ml; closed symbols) for indicated time periods or left untreated (open symbols), after which lipids
were extracted and analyzed by TLC. Data are expressed as a percentage of SM (circles) and multiple-fold increase in Cer (triangles)
relative to an untreated control sample harvested just before the start of the experiment. (B) Effect of fumonisin B1 (FB1) on CD95-
induced Cer formation. Jurkat cells labeled to equilibrium with [14C]serine were preincubated for 24 h without (medium) or with 25 mM
FB1 (1FB1), washed, resuspended in medium with or without 25 mM FB1, and stimulated with anti-CD95 mAb (200 ng/ml; closed
bars) or left untreated (open bars). After 3 h, lipids were extracted and Cer was quantified. Data (means 6 SD) represent two indepen-
dent experiments. The Cer response is indicated as a percentage of untreated control cells. Note that, as expected, FB1 reduces absolute
[14C]Cer levels as defined in Materials and Methods. (Inset) Effect of FB1 on SM synthesis. Cells were preincubated with 25 mM FB1
for time periods indicated, after which [14C]serine was added for an additional 36 h. Lipids were extracted and SM was quantified. Re-
sults are expressed as a percentage of untreated control cells and are representative of two experiments. (C) The pool of SM hydrolyzed
upon CD95 stimulation is fully accessible to an exogenous SMase. Jurkat cells metabolically labeled with [14C]choline were treated with
B. cereus SMase (200 mU/ml) alone (closed circles) or with SMase plus anti-CD95 mAb (200 ng/ml; open squares). At various time
points, samples were analyzed for radiolabeled SM and PC content. The ratio of SM relative to PC is expressed as a percentage of con-
trol. This experiment was performed twice with similar results. 
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from phosphocholine directly and intracellularly, by CTP:
phosphocholine cytidylyltransferase, a regulatory enzyme
in PC biosynthesis (Kent, 1997). Since we found no PC
hydrolysis (already noted above), the increased level of
CDP-choline can only be derived from SMase-produced
phosphocholine, which is directly channeled from inner-
leaflet SM via the cytidylyltransferase into CDP-choline.
In principle, transbilayer movement of SM during lipid
scrambling should be measurable with fluorescent NBD-
SM, since internalized NBD-SM will be sequestered from
BSA back extraction. However, CD95-stimulated Jurkat
cells displayed no sequestration of NBD-SM, whereas they
did show enhanced internalization of NBD-PC, which
temporally paralleled PS exposure, indicative of enhanced
nonspecific PL scrambling (Bratton et al., 1997; data not
 
shown). Apparently, NBD-SM hydrolysis (Fig. 3, A and
B) occurs rapidly after its internalization, after which the
neutral lipid product NBD-Cer can freely flip-flop to the
outer leaflet (Pagano, 1989) to become available again for
back extraction by BSA. Indeed, we found that 87% of the
NBD-Cer produced upon CD95 stimulation was suscepti-
ble to BSA back extraction (data not shown). Together,
the data suggest that activation of nonspecific PL scram-
bling in the plasma membrane not only results in PS expo-
sure and NBD-PC internalization, but also in internaliza-
tion of NBD-SM, which is immediately hydrolyzed and
back-extracted as NBD-Cer.
 
Phospholipid Scrambling Is Necessary and Sufficient 
for Cer Formation
 
To address the question of whether lipid scrambling activ-
ity is necessary for Cer formation, we used the Burkitt
lymphoma cell line Raji, which is defective in PS exposure
in response to a rise in intracellular Ca
 
2
 
1
 
 levels (Zhao et al.,
1998) or apoptotic stimuli (Frey, 1997; Fadeel et al., 1999).
CD95 stimulation of Raji cells did not result in Cer forma-
tion nor significant PS exposure up to 8 h after stimulation,
whereas two other apoptotic features, loss of mitochon-
drial transmembrane potential (
 
DC
 
m
 
) and nuclear frag-
mentation, became evident after 2 h of incubation (Fig. 4
A). In addition, when NBD-SM was presented to Raji
cells undergoing apoptosis in response to CD95 stimula-
tion, no hydrolysis to NBD-Cer was observed (Fig. 4 B).
Thus, consistent with the tight connection between scram-
bling of membrane phospholipids and Cer formation,
analysis of the Raji cells revealed that phospholipid scram-
Figure 3. Cer is derived from the SM originally
present in the outer leaflet of the plasma mem-
brane. (A) CD95 induces hydrolysis of exoge-
nous fluorescent NBD-SM. Jurkat cells were in-
cubated with 4 mM NBD-SM 10 min before CD95
stimulation (200 ng mAb/ml) for the times indi-
cated. NBD-lipids were extracted, separated by
TLC, visualized under UV light, and photo-
graphed. The identities of NBD-Cer and NBD-
GlcCer (NBD-glucosylceramide) were estab-
lished using co-chromatography of commercially
obtained lipid standards. NBD-Cer formation
was most easily detected when the lipid probe
was continuously present during stimulation, but
significant NBD-SM hydrolysis in CD95-stimu-
lated cells was also observed when NBD-SM was
added during the last 15 min of incubation (re-
sults not shown). (B) Quantitation of the NBD-
Cer spots shown in A by fluorescence spectro-
photometry (expression in arbitrary units). (C)
NBD-Cer is derived from outer leaflet NBD-SM.
Jurkat cells were incubated with 4 mM NBD-SM
during 30 min at 378C to allow labeling of intra-
cellular and plasma membranes, followed or not
followed by BSA back extraction (see Materials
and Methods). Cells resuspended in H/H were warmed to 378C and exposed to anti-CD95 mAb (200 ng/ml; 1) or left untreated (2).
Lipids were extracted and analyzed by TLC after the indicated time periods. The BSA extraction protocol did not affect apoptosis in-
duction, as verified by nuclear fragmentation (data not shown). (D) DNA damage–induced NBD-SM hydrolysis in SKW6.4 cells, 14 or
16 h after exposure to etoposide (5 mg/ml; Eto) or radiation (20 Gy; g-IR), NBD-SM (4 mM) was presented during 20 min to SKW6.4.
TLC analysis indicates increased NBD-SM hydrolysis to NBD-Cer in cells undergoing apoptosis relative to untreated control cells
(con).
 
Table I. CD95-induced Increase in the Intracellular Level
of CDP-choline
 
Time CDP-choline Phosphocholine
 
min
 
0 267 
 
6
 
 65 (100%) 8,007 
 
6
 
 476 (100%)
30 261 
 
6 
 
25 (98%) 7,442 
 
6
 
 503 (93%)
60 554 
 
6
 
 110 (208%)  8,484 
 
6
 
 98 (106%)
90 804 
 
6
 
 155 (301%) 5,813 
 
6
 
 834 (73%)
 
Jurkat cells were labeled to equilibrium with [
 
14
 
C]choline chloride, stimulated with
anti-CD95 mAb for the indicated times, and cell-associated, water-soluble
phosphocholine metabolites were extracted and separated by TLC, as described in
Materials and Methods. Data, in [
 
14
 
C]arbitrary (PhosphorImager) units, show the
mean 
 
6
 
 range of two data points from a representative experiment (out of three). The
apparent decrease in intracellular phosphocholine levels after 90 min of stimulation
probably reflects the release of membrane vesicles, resulting in an overall loss of cell
material that is pelleted at 14,000 
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bling is required for Cer formation. Another important
conclusion drawn from these results is that, at least in
these cells, Cer formation is not required for apoptotic al-
terations in mitochondria and the nucleus to occur.
To determine whether SM hydrolysis to Cer is the im-
mediate consequence of the loss of phospholipid asymme-
try, lipid scrambling was induced directly by elevating in-
tracellular Ca21 levels (Williamson et al., 1992; Smeets et al.,
1994; Zhou et al., 1998). Accordingly, the Ca21 ionophore
ionomycin, caused rapid surface exposure of PS in Jurkat
but not in Raji cells (Fig. 4 C). Remarkably, ionomycin
also induced the conversion of NBD-SM to NBD-Cer in
Jurkat but not in Raji cells (Fig. 4 D). NBD-SM conver-
sion was time-dependent, with kinetics similar to those of
PS exposure. No metabolism of NBD-PC was observed
under these conditions (data not shown). EGTA inhibited
ionomycin-induced PS exposure and NBD-SM hydrolysis,
indicating that both events require extracellular Ca21 (re-
sults not shown). We conclude that the loss of phospho-
lipid asymmetry is both necessary and sufficient for SM to
be hydrolyzed intracellularly.
Plasma Membrane SM Content Affects Apoptotic
Cell-surface Morphology
Given that SM conversion to Cer occurs during the execu-
tion phase of apoptosis, but seems to be dispensable for
nuclear apoptosis or mitochondrial depolarization (see
Fig. 4 A), the question arises whether it contributes to other
apoptotic characteristics, such as altered cell-surface mor-
phology. We noticed that Raji cells, undergoing apoptosis,
barely displayed the typical small surface blebs and release
of membrane vesicles that are characteristic of normal
apoptotic lymphoid cells. Rather, Raji cells adopted elon-
gated, sausagelike shapes (Fig. 5). To examine whether
SMase activity but not Cer production is necessary for
membrane blebbing during apoptosis, NBD-SM was re-
plenished to CD95-stimulated Jurkat cells. Strikingly, the
extensive cell-surface blebbing and vesicle shedding nor-
mally observed in Jurkat cells was completely inhibited
when NBD-SM was present in the medium (Fig. 5). More-
over, the shape of the cells in the presence of NBD-SM re-
sembled that of CD95-stimulated Raji cells. Both the polar
headgroup and the sphingoid base moiety of NBD-SM
were required for the inhibition of blebbing, since neither
NBD-Cer nor NBD-PC affected the apoptotic morphol-
ogy of Jurkat cells (data not shown). We conclude that the
lack of plasma membrane SM hydrolysis in Raji cells, or
replenishment of the SM hydrolyzed in Jurkat cells, pre-
vents the formation of apoptotic blebs and shedding of
membrane vesicles. Evidently, the physiological signifi-
cance of SM hydrolysis relates to apoptotic cell-surface
morphology, and lies in plasma membrane SM depletion,
rather than the generation of Cer.
Why Is Plasma Membrane SM Content Important?
To understand how plasma membrane SM content can af-
fect cell-surface morphology, it is important to recognize
that SM has a high affinity for cholesterol and retains cho-
Figure 4. Scrambling of plasma membrane phos-
pholipids, monitored by annexin V staining (PS
exposure), is necessary and sufficient for Cer for-
mation. (A) Raji cells show no CD95-induced PS
exposure, nor Cer formation, yet exhibit loss of
mitochondrial transmembrane potential (DCm)
and nuclear fragmentation. Cells labeled with
[14C]serine were exposed to anti-CD95 mAb
(200 ng/ml) for the indicated time periods and
[14C]Cer was quantified. PS exposure (annexin V
staining),  DCm (measured with the fluorescent
dye DiOC6(3)), and nuclear fragmentation were
determined in parallel. (B) Absence of NBD-SM
hydrolysis to NBD-Cer in CD95-stimulated Raji
cells. Cells were incubated with 4 mM NBD-SM
10 min before the addition of anti-CD95 mAb
(200 ng/ml). At the indicated time points, total
lipids were extracted and separated by TLC. A
commercial NBD-Cer standard was run in paral-
lel. (C) Ionomycin induces PS exposure in Jurkat
but not in Raji cells. Cells were exposed to 5 mM
ionomycin for the indicated time periods or left
untreated (control; con), and PS exposure was
detected using FITC-labeled annexin V. Histo-
grams are representative of at least three experi-
ments. (D) Ionomycin induces NBD-SM hydro-
lysis to NBD-Cer in Jurkat but not in Raji cells.
Cells preincubated for 10 min with 4 mM NBD-
SM were exposed to 5 mM ionomycin or its sol-
vent (control) for the times indicated, after
which lipids were extracted and separated by
TLC. NBD-Cer fluorescence was quantified us-
ing fluorescence spectrophotometry.Tepper et al. Phospholipid Scrambling and Ceramide Formation 161
lesterol in the plasma membrane (Wattenberg and Silbert,
1983; van Blitterswijk et al., 1987). Both lipids are major
determinants for the biophysical properties of the lipid bi-
layer, such as membrane fluidity and structural integrity,
also in functional membrane domains (Simons and Ikonen,
1997; Anderson, 1998). SM hydrolysis by exogenous
SMase disturbs the physical association with cholesterol,
resulting in the redistribution of cholesterol from the
plasma membrane to intracellular compartments (Neufeld
et al., 1996; Ohvo et al., 1997) or to extracellular acceptors
(Rothblat et al., 1999). We used MbCD, a specific and well
established cholesterol acceptor (Yancey et al., 1996), to
examine whether CD95-induced SM hydrolysis altered
cholesterol packing with plasma membrane PL, resulting
in increased cholesterol efflux from that membrane to-
wards MbCD. Treatment of [3H]cholesterol-labeled cells
with bacterial SMase resulted in enhanced MbCD-medi-
ated efflux of [3H]cholesterol (Fig. 6 A). Similarly, cho-
lesterol was more readily removed from cells undergoing
CD95-induced apoptosis when compared with time-matched
control cells (Fig. 6 B). The effect became discernible be-
tween 1 and 2 h of stimulation, which is consistent with
the kinetics of SM hydrolysis. From these data, we con-
clude that degradation of plasma membrane SM, either
upon exposure to bacterial SMase or by endogenous
SMase during CD95 stimulation, decreases plasma mem-
brane cholesterol content. The concomitant loss of SM
and cholesterol during apoptosis will fluidize and destabi-
lize (domains in) the plasma membrane, enabling mem-
brane blebbing (zeiosis) and the shedding of membrane
vesicles.
Discussion
This study provides novel insights into both the mecha-
nism and the physiological relevance of Cer formation in
the execution phase of apoptosis. We found a previously
unrecognized connection between two apoptotic features:
Cer formation and cell-surface PS exposure. Both events
are the immediate consequence of loss of plasma mem-
Figure 5. Plasma membrane
SM content determines sur-
face morphology of apop-
totic cells. Raji and Jurkat
cells suspended at 2.5 3 106
cells per ml in H/H medium
without (medium) or with 4
mM NBD-SM (NBD-SM)
were left untreated (control)
or exposed to anti-CD95
mAb (200 ng/ml) for 6 h
(Raji) or 1.5 h (Jurkat). Cells
were viewed and photo-
graphed using a light trans-
mission microscope with a
403  objective.
Figure 6. Enhanced efflux
of [3H]cholesterol from the
plasma membrane during
apoptosis induction. (A)
Depletion of SM from the
plasma membrane by exoge-
nous SMase enhances ef-
flux of membrane choles-
terol to methyl-b-cyclodextrin
(MbCD), which is a specific
cholesterol acceptor. Jurkat
cells were labeled with
[3H]cholesterol and resus-
pended in 0.08% MbCD. Af-
ter a 3-min incubation at
378C, cells were treated with 150 mU/ml B. cereus SMase (bSMase; closed squares) or left untreated (open squares). At different time
intervals, the radioactivity that released into the extracellular medium was determined by liquid scintillation counting. Date shown are
from one experiment with single point determinations, representative of at least five independent experiments. (B) Cells induced to un-
dergo apoptosis (200 ng/ml; anti-CD95 mAb, closed symbols) or left untreated (open symbols) were pelleted after 1-, 2-, 3-, or 4-h incu-
bation (indicated) and resuspended in medium containing 0.08% MbCD. After different incubation periods at 378C, radioactivity which
was released into the medium, was determined by liquid scintillation counting. Data are expressed as a percentage of radioactive choles-
terol initially present in the cells and represent one out of three independent experiments with similar results.The Journal of Cell Biology, Volume 150, 2000 162
brane PL asymmetry. This holds for several apoptotic sys-
tems, T and B lymphoid cells challenged by CD95 ligation,
etoposide, or g-radiation. Furthermore, we show that this
late Cer formation is not required for major characteristics
of apoptosis, such as a loss of mitochondrial transmem-
brane potential and nuclear fragmentation. Rather, the
physiological relevance of Cer formation in the effector
phase of apoptosis relates to the changes of cell-surface
morphology. Not the production of Cer as such, but the
depletion of its precursor SM in the plasma membrane is
responsible for cholesterol efflux and, thus, major changes
in membrane structure and fluidity, which allow mem-
brane blebbing and vesicle formation at the cell surface.
This study does not resolve the controversial issue about
a possible existence and the function of rapid Cer forma-
tion (in minutes) in apoptosis induction. Despite extensive
lipid analyses, using three different assays as well as inhib-
itors of Cer clearance, we have not been able to detect
rapid Cer formation in Jurkat T cells or JY (Epstein-Barr
virus–transformed) B cells in response to either CD95 li-
gation, etoposide, or g-radiation (Tepper et al., 1997, 1999;
Boesen-de Cock et al., 1998). Yet, it can not be excluded
that (in other systems) such a rapid Cer response exists.
Cer Formation Results from a Loss of Plasma 
Membrane Phospholipid Asymmetry
Our data strongly support the causal relationship between
plasma membrane PL scrambling and the hydrolysis of
SM to Cer. PL scrambling is both sufficient and necessary
for SM hydrolysis: Ca21-induced scrambling (PS exposure)
associates with Cer formation, whereas scrambling-defi-
cient Raji cells fail to hydrolyze SM. The defect in Raji
cells that renders them scrambling deficient is unknown.
The mere reconstitution of PL scramblase expression by
retroviral gene transduction is not sufficient to restore PS
exposure in these cells (Fadeel et al., 1999; Tepper, A.D.,
unpublished data).
Fig. 7 illustrates the sequence of events in the plasma
membrane as suggested by our data: apoptotic stimuli
or elevated Ca21 induce the counterbalancing flip-flop
(scrambling) of PS and PE, originally residing in the inner
leaflet, and SM and PC, originally located in the outer
leaflet. Internalized SM becomes accessible to cytosolic
SMase, leading to the formation of Cer. This scenario is
supported by three pieces of evidence. First, CD95 stimu-
lation induces Cer formation from an SM pool that is
accessible to an exogenous SMase. Second, exogenous
NBD-SM that, by definition, first inserts into the outer
leaflet, is hydrolyzed to NBD-Cer upon an apoptotic stim-
ulus or ionomycin. Thus, NBD-SM has to flip to the inner
leaflet to be degraded to NBD-Cer by an SMase inside the
cell. NBD-SM internalized otherwise (e.g., by endocyto-
sis) represents a different pool, which is not inducibly hy-
drolyzed to NBD-Cer. The third piece of evidence is the
elevation of intracellular CDP-choline levels in apoptotic
cells, reflecting liberation of the SMase product phospho-
choline in the cytosol (Table I). Since levels of other
choline metabolites remained unchanged, we interpret
these data as a compartmentalized (channeled) reaction
in which SM-derived phosphocholine is directly converted
into CDP-choline by a cytidylyltransferase (Kent, 1997).
Accumulation of CDP-choline does not occur in normal
viable cells, but has been encountered in apoptotic cells,
also by others (Anthony et al., 1999), and indicates a block
in PC synthesis at the level of CDP-choline:1,2-diacylglyc-
erol cholinephosphotransferase.
From our present and previous work (Boesen-de Cock
et al., 1998; Tepper et al., 1999), it follows that a neutral
SMase activity must be responsible for late Cer formation
in Jurkat cells. As argued above and by other authors
(Linardic and Hannun, 1994; Andrieu et al., 1996; Liu et al.,
1998), SMase acts at the cytosolic side of the plasma mem-
brane. However, contrary to results of Andrieu et al.
(1996) on tumor necrosis factor a–stimulated fibroblasts,
we find that SM hydrolysis inside the cell is tightly linked
to preceding transbilayer movement of SM, since de-
pletion of exoleaflet NBD-SM by BSA prevented CD95-
induced NBD-Cer formation. Although we can not
exclude that an activation step is needed to hydrolyze in-
ternalized SM, we did not detect increased in vitro SMase
activity in lysates of Jurkat cells after CD95 stimulation or
treatment with ionomycin (data not shown). Thus, our
data are consistent with the possibility that SM to Cer con-
version is solely controlled by substrate availability.
The signal transduction underlying PL scrambling in
apoptotic cells remains to be elucidated. PS exposure in-
duced by many different apoptotic stimuli has been shown
to require inducer caspase activation (Martin et al., 1996;
Vanags et al., 1996; Zhuang et al., 1998; this study). While
both inactivation of aminophospholipid translocase and
activation of PL scramblase may, in concert, determine PL
scrambling, there is no evidence that these enzymes are di-
rect targets for caspases (Verhoven et al., 1999; Tepper,
A.D., unpublished data). A role for intracellular Ca21 as a
regulator of PS exposure on apoptotic cells was proposed
in a number of studies (Verhoven et al., 1995, 1999; Hamp-
ton et al., 1996; Bratton et al., 1997; this study). Mitochon-
drial changes were suggested to act upstream of PS expo-
sure  during apoptosis induction (Martin et al., 1995;
Zhuang et al., 1998), and recent work has implicated the
active participation of mitochondria in cellular Ca21 sig-
naling (Szalai et al., 1999; Zhu et al., 1999). Therefore, it is
tempting to speculate that Ca21 release from mitochondria
plays a role in activation of PL scrambling.
Structural and Morphological Changes at the
Plasma Membrane
While our results do not support (but neither exclude) a
role for Cer in the apoptotic process, they implicate SM
depletion to facilitate membrane blebbing and vesicula-
tion since these features are absent in Raji cells, where PL
scrambling and SM hydrolysis do not take place. Consis-
tent with this notion, in Jurkat cells, these morphological
changes are prevented when hydrolyzed SM is replenished
by NBD-SM. In activated platelets, PS exposure serves to
provide a procoagulant surface (for review see Zwaal and
Schroit, 1997). In these cells, a causal relationship between
PL scrambling and the shedding of vesicles (microparti-
cles) from the plasma was earlier suggested by Sims et al.
(1989). The onset of NBD-PS exposure at the surface of
activated platelets coincided with the onset of plasma
membrane vesiculation (Chang et al., 1993), and shed mi-Tepper et al. Phospholipid Scrambling and Ceramide Formation 163
croparticles from erythrocytes were reported to have a
more random PL distribution compared with the remnant
cells (Comfurius et al., 1990).
We propose the following explanation for the observed
relationship between SM breakdown and vesiculation at
the plasma membrane. SM preferentially associates with
cholesterol, which is a major determinant of the structural
order (i.e., reciprocal of fluidity) and integrity of the
plasma membrane (van Blitterswijk et al., 1982, 1987;
Wattenberg and Silbert, 1983). Depletion of SM causes re-
distribution of cholesterol to intracellular sites, and/or it
enhances cholesterol efflux to natural or artificial external
acceptors, such as serum lipoproteins and MbCD, respec-
tively (Slotte and Bierman, 1988, Ohvo et al., 1997; Roth-
blat et al., 1999; Fig. 7). We found that SM breakdown
during apoptosis resulted in an increased efflux of choles-
terol, which, conceivably, leads to increased fluidity of the
plasma membrane (van Blitterswijk et al., 1987). Such
membrane destabilization may facilitate processes like en-
docytosis from coated pits (Montesano et al., 1979), mem-
brane blebbing (this study), and shedding of vesicles (van
Blitterswijk et al., 1982; Chang et al., 1993). Membrane
blebbing during apoptosis was suggested to involve con-
traction of cortical actin, and it was proposed that the bleb
protrusions result from focal regions where the plasma
membrane is no longer anchored to the cytoskeleton
(Mills et al., 1999). Recent findings implicated sphin-
golipid/cholesterol microdomains (rafts) in the regulation
of plasma membrane–cytoskeleton interactions (Olifer-
enko et al., 1999). It can be envisioned that plasma mem-
brane SM depletion destabilizes raft integrity, and that
the disturbance of the interaction between raft proteins
and the underlying cytoskeleton contributes to membrane
blebbing.
In conclusion, we propose a new mechanism that con-
trols SM hydrolysis to Cer during the execution phase of
apoptosis. This mechanism relies on the loss of PL asym-
metry in the plasma membrane. While attention has long
been focused solely on Cer as a putative apoptotic second
messenger, our data introduce a new twist by suggesting
that the breakdown of the SM is essential for at least
one morphological characteristic of apoptosis, membrane
blebbing, and vesicle formation at the cell surface.
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